Hyperfractionated accelerated radiotherapy for carcinoma of the oesophagus.

Hyperfractionated accelerated radiotherapy for carcinoma of the oesophagus. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Hyperfractionated accelerated radiotherapy for carcinoma of the oesophagus. Abstract Text:

We report on 48 patients with carcinoma of the oesophagus treated by hyperfractionated accelerated radiotherapy. The patients, aged 46 to 93 years, were considered suitable for radiotherapy on their performance status irrespective of the presence of metastases. The radiotherapy was given three times a day over 2 weeks with a minimum of 3 h between treatments. The treatment was well tolerated acutely and to date there have been no unacceptable long-term side-effects. Dysphagia was improved in 39 (81.2%) patients. Product-limit survival was 35.7%, 18.5% and 12.3% at 1, 2 and 3 years. We conclude that this regime is feasible within the normal working day, well tolerated, effective and the shorter overall treatment duration desirable.

Hyperfractionated accelerated radiotherapy for carcinoma of the oesophagus. Publishing Authors By Initials

For similar natural sciences: time: time factors research abstracts see: natural sciences: time: time factors research

PUBMED ID PMID:

MEDLINE DATE:

Hyperfractionated accelerated radiotherapy for carcinoma of the oesophagus. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Clinical oncology (Royal College of Radiologists (

VOLUME: 3

Page Numbers: 209-13

Journal Abbreviation: Clin Oncol (R Coll Radiol)

ISSN: 0936-6555

DAY: 10

MONTH: Jul

YEAR: 1991

Hyperfractionated accelerated radiotherapy for carcinoma of the oesophagus. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9002902

Hyperfractionated accelerated radiotherapy for carcinoma of the oesophagus. Keywords Mesh Terms:

KEYWORDS: Time Factors

MESH TERMS: radiotherapy

Chemical & Substance for Abstract: Hyperfractionated accelerated radiotherapy for carcinoma of the oesophagus. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Hyperfractionated accelerated radiotherapy for carcinoma of the oesophagus.

AFFILIATION: Department of Radiotherapy, North Staffordshire Royal Infirmary, Stoke-on-Trent, UK.

Country: ENGLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Clin Oncol (R Coll Radiol)

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Hyperfractionated accelerated radiotherapy for carcinoma of the oesophagus Related Publications

• Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (FHHNC): compound heterozygous mutation in the claudin 16 (CLDN16) gene.
• Hyperfractionated accelerated radiotherapy for carcinoma of the oesophagus.
• Hyperfractionated accelerated radiotherapy for carcinoma of the oesophagus.
• Para-aortic nodal irradiation for early stage testicular seminoma.
• The web and the structure of taxonomy.